Wall Street analysts forecast that Medical Properties Trust, Inc. (NYSE:MPW) will post earnings per share of $0.31 for the current quarter, Zacks reports. Eight analysts have made estimates for Medical Properties Trust’s earnings, with the highest EPS estimate coming in at $0.33 and the lowest estimate coming in at $0.29. Medical Properties Trust posted earnings of $0.35 per share during the same quarter last year, which suggests a negative year over year growth rate of 11.4%. The firm is scheduled to report its next earnings report on Thursday, November 7th.

According to Zacks, analysts expect that Medical Properties Trust will report full year earnings of $1.30 per share for the current year, with EPS estimates ranging from $1.25 to $1.32. For the next fiscal year, analysts forecast that the firm will post earnings of $1.57 per share, with EPS estimates ranging from $1.53 to $1.61. Zacks Investment Research’s EPS averages are an average based on a survey of research firms that that provide coverage for Medical Properties Trust.

Medical Properties Trust (NYSE:MPW) last released its earnings results on Thursday, August 1st. The real estate investment trust reported $0.31 EPS for the quarter, hitting analysts’ consensus estimates of $0.31. The company had revenue of $192.55 million during the quarter, compared to analysts’ expectations of $186.11 million. Medical Properties Trust had a net margin of 129.20% and a return on equity of 6.84%. Medical Properties Trust’s revenue for the quarter was down 4.6% on a year-over-year basis. During the same period last year, the business earned $0.36 EPS.

A number of research firms recently commented on MPW. Deutsche Bank upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a research note on Monday, July 29th. Zacks Investment Research lowered shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a research report on Wednesday, July 17th. SunTrust Banks raised their price target on shares of Medical Properties Trust from $20.00 to $21.00 and gave the stock a “buy” rating in a research report on Tuesday, August 27th. Stifel Nicolaus set a $21.00 price target on shares of Medical Properties Trust and gave the stock a “buy” rating in a research report on Monday, August 12th. Finally, JPMorgan Chase & Co. set a $21.00 price target on shares of Medical Properties Trust and gave the stock a “buy” rating in a research report on Wednesday, September 4th. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the stock. Medical Properties Trust currently has an average rating of “Buy” and a consensus target price of $19.59.

MPW stock traded up $0.09 during trading on Friday, reaching $19.04. The company had a trading volume of 6,920,321 shares, compared to its average volume of 3,492,409. The firm has a 50-day simple moving average of $18.41 and a 200-day simple moving average of $18.17. The company has a market cap of $8.46 billion, a price-to-earnings ratio of 13.90, a price-to-earnings-growth ratio of 3.64 and a beta of 0.56. The company has a debt-to-equity ratio of 0.99, a quick ratio of 8.00 and a current ratio of 8.00. Medical Properties Trust has a twelve month low of $13.98 and a twelve month high of $19.26.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 10th. Shareholders of record on Thursday, September 12th will be given a dividend of $0.26 per share. The ex-dividend date of this dividend is Wednesday, September 11th. This is a positive change from Medical Properties Trust’s previous quarterly dividend of $0.25. This represents a $1.04 dividend on an annualized basis and a yield of 5.46%. Medical Properties Trust’s dividend payout ratio (DPR) is currently 75.91%.

In other Medical Properties Trust news, insider Emmett E. Mclean sold 100,000 shares of the firm’s stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $18.37, for a total transaction of $1,837,000.00. Following the completion of the transaction, the insider now directly owns 1,066,337 shares of the company’s stock, valued at approximately $19,588,610.69. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director G Steven Dawson purchased 7,476 shares of Medical Properties Trust stock in a transaction on Thursday, August 8th. The shares were acquired at an average cost of $18.07 per share, with a total value of $135,091.32. Following the completion of the transaction, the director now directly owns 76,302 shares in the company, valued at approximately $1,378,777.14. The disclosure for this purchase can be found here. Company insiders own 1.18% of the company’s stock.

Large investors have recently bought and sold shares of the company. Cullen Frost Bankers Inc. increased its holdings in shares of Medical Properties Trust by 70.9% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 1,832 shares of the real estate investment trust’s stock valued at $32,000 after purchasing an additional 760 shares in the last quarter. Manchester Financial Inc. purchased a new position in shares of Medical Properties Trust during the 2nd quarter valued at approximately $33,000. Cascade Investment Advisors Inc. purchased a new position in shares of Medical Properties Trust during the 2nd quarter valued at approximately $35,000. Princeton Global Asset Management LLC purchased a new position in shares of Medical Properties Trust during the 1st quarter valued at approximately $37,000. Finally, Icon Wealth Partners LLC purchased a new position in shares of Medical Properties Trust during the 1st quarter valued at approximately $42,000. 71.33% of the stock is owned by hedge funds and other institutional investors.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Featured Story: Momentum Investing

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.